分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

Phase separation of insulin receptor substrate 1 drives the formation of insulin/IGF-1 signalosomes

Gao Xiu Kui, Rao Xi Sheng, Cong Xiao Xia, Sheng Zu Kang, Sun Yu Ting, Xu Shui Bo, Wang Jian Feng, Liang Yong Heng, Lu Lin Rong, Ouyang Hongwei, Ge Huiqing, Guo Jian-sheng, Wu Hang-jun, Sun Qi Ming, Wu Hao-bo, Bao Zhang, Zheng Li Ling, Zhou Yi Ting

Journal:Cell Discovery

IF:38.08

DOI:10.1038/s41421-022-00426-x

PMID:35764611

Published:2022-06-28

research field:分子生物学生物信息学家禽科学药理学免疫学

Abstract

As a critical node for insulin/IGF signaling, insulin receptor substrate 1 (IRS-1) is essential for metabolic regulation. A long and unstructured C-terminal region of IRS-1 recruits downstream effectors for promoting insulin/IGF signals. However, the underlying molecular basis for this remains elusive. Here, we found that the C-terminus of IRS-1 undergoes liquid-liquid phase separation (LLPS). Both electrostatic and hydrophobic interactions were seen to drive IRS-1 LLPS. Self-association of IRS-1, which was mainly mediated by the 301–600 region, drives IRS-1 LLPS to form insulin/IGF-1 signalosomes. Moreover, tyrosine residues of YXXM motifs, which recruit downstream effectors, also contributed to IRS-1 self-association and LLPS. Impairment of IRS-1 LLPS attenuated its positive effects on insulin/IGF-1 signaling. The metabolic disease-associated G972R mutation impaired the self-association and LLPS of IRS-1. Our findings delineate a mechanism in which LLPS of IRS-1-mediated signalosomes serves as an organizing center for insulin/IGF-1 signaling and implicate the role of aberrant IRS-1 LLPS in metabolic diseases.

本文使用的Yeasen产品

购物车
客服
转染试用